Please assess the completion status of the following clinical trial:

Trial Title: KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Be a candidate for routine, uncomplicated cataract surgery~Exclusion Criteria:~* Have a post-traumatic cataract.~* Have suspected permanent low vision or blindness in the fellow non-study eye.~* Have active uveitis in either eye.~* Have an ocular neoplasm in either eye.~* Have the presence of viral, bacterial, or fungal disease in either eye.~* Have glaucoma, ocular hypertension, steroid-induced IOP (intraocular pressure) rise or elevated IOP

- Gender: ALL
- Minimum Age: None
- Maximum Age: 3 Years
- Healthy Volunteers: f

Study Arms:
- KPI-121 1% BID (twice daily) (Type: EXPERIMENTAL): None
- Prednisolone acetate QID (four times daily) (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).